RNA polymerase III transcription as a disease factor.

Détails

Ressource 1Télécharger: Genes Dev.-2020-Yeganeh-865-82.pdf (1257.06 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_05D97F79A5F4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
RNA polymerase III transcription as a disease factor.
Périodique
Genes & development
Auteur⸱e⸱s
Yeganeh M., Hernandez N.
ISSN
1549-5477 (Electronic)
ISSN-L
0890-9369
Statut éditorial
Publié
Date de publication
01/07/2020
Peer-reviewed
Oui
Volume
34
Numéro
13-14
Pages
865-882
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
RNA polymerase (Pol) III is responsible for transcription of different noncoding genes in eukaryotic cells, whose RNA products have well-defined functions in translation and other biological processes for some, and functions that remain to be defined for others. For all of them, however, new functions are being described. For example, Pol III products have been reported to regulate certain proteins such as protein kinase R (PKR) by direct association, to constitute the source of very short RNAs with regulatory roles in gene expression, or to control microRNA levels by sequestration. Consistent with these many functions, deregulation of Pol III transcribed genes is associated with a large variety of human disorders. Here we review different human diseases that have been linked to defects in the Pol III transcription apparatus or to Pol III products imbalance and discuss the possible underlying mechanisms.
Mots-clé
Alu, BC200, RMRP, RNA polymerase III, cancer, disease, leukodystrophy, nc886, tRNA, transcription
Pubmed
Open Access
Oui
Création de la notice
08/07/2020 13:21
Dernière modification de la notice
21/11/2022 9:30
Données d'usage